Quarterly report · Q2
9993.TEDINET S100S0BM
Period2023-03-01 → 2023-08-31
Filed2023-10-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥50.6bn | 2023-03-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥99.5bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥50.3bn | 2022-03-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥532m | 2023-03-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥683m | 2022-03-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥570m | 2023-03-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥928m | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥726m | 2022-03-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥587m | 2023-03-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥663m | 2022-03-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.0bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥205m | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥433m | 2022-03-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.0bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥433m | 2022-03-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥56.0bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥54.3bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥50.5bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥26.5bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥25.6bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥29.5bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥28.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥29.2bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.4bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.0bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2022-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.1bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.2bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.8bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.1bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.3bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥177m | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.4bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥483m | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥95.13 | 2023-03-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.32 | 2023-06-01 → 2023-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.9 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.78 | 2022-03-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.08 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥95.06 | 2023-03-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.88 | 2022-03-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥39.75 | 2022-03-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 52.7% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.8% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.7% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-03-01 → 2023-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-03-01 → 2023-08-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-03-01 → 2023-08-31 | ¥78m |
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-08-31 | ¥5m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2023-03-01 → 2023-08-31 | ¥36m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2023-03-01 → 2023-08-31 | ¥44.5bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2023-03-01 → 2023-08-31 | ¥44.2bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥297m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2023-03-01 → 2023-08-31 | ¥412m |
| —segment total | revenue | 2023-03-01 → 2023-08-31 | ¥50.9bn |
| —segment total | revenue external | 2023-03-01 → 2023-08-31 | ¥50.6bn |
| —segment total | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥297m |
| —segment total | segment profit | 2023-03-01 → 2023-08-31 | ¥449m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-03-01 → 2023-08-31 | ¥53.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-03-01 → 2023-08-31 | ¥50.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-03-01 → 2023-08-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-03-01 → 2023-08-31 | ¥527m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-03-01 → 2022-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-03-01 → 2022-08-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-03-01 → 2022-08-31 | ¥56m |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-08-31 | −¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-08-31 | −¥2m |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥6.5bn |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥0 |
| jpcrp040300-q2r_E03228-000Drugstore Businessreportable segment | segment profit | 2022-03-01 → 2022-08-31 | ¥49m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue | 2022-03-01 → 2022-08-31 | ¥44.1bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue external | 2022-03-01 → 2022-08-31 | ¥43.8bn |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥299m |
| jpcrp040300-q2r_E03228-000Supermarket Businessreportable segment | segment profit | 2022-03-01 → 2022-08-31 | ¥579m |
| —segment total | revenue | 2022-03-01 → 2022-08-31 | ¥50.6bn |
| —segment total | revenue external | 2022-03-01 → 2022-08-31 | ¥50.3bn |
| —segment total | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥299m |
| —segment total | segment profit | 2022-03-01 → 2022-08-31 | ¥628m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-03-01 → 2022-08-31 | ¥52.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-03-01 → 2022-08-31 | ¥50.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-03-01 → 2022-08-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-03-01 → 2022-08-31 | ¥685m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 461
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)髙 嶋 清 彦 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)大 倉 克 俊 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 50309000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 50650000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 99457000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 726000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 570000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 928000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 433000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1024000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 205000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 443000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 1036000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 246000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 29157000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 29532000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 28636000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 50493000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 56031000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 54259000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 39.78 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 95.13 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 18.90 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 39.75 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 95.06 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 18.88 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.577 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.527 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.528 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 2245000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 3075000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1931000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -2259000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -1803000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -7128000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -483000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -177000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 4402000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 5225000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 6022000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 4927000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 23.08 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 32.32 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10960825 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10960825 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 10960825 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 10960825 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |